• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human E3 ubiquitin-protein ligase TRIM50 (TRIM50)

ACP15675

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15675 Target NameTRIM50
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-487Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ86XT4
Background Information
  • Uniprot Id

    Q86XT4

  • Target Species

    Human

  • Target Name

    TRIM50

  • Target Full Name

    E3 ubiquitin-protein ligase TRIM50

  • Target Function

    E3 ubiquitin-protein ligase that ubiquitinates Beclin-1/BECN1 in a 'Lys-63'-dependent manner enhancing its binding to ULK1. In turn, promotes starvation-induced autophagy activation. Interacts also with p62/SQSTM1 protein and thereby induces the formation and the autophagy clearance of aggresome-associated polyubiquitinated proteins through HDAC6 interaction.

  • Target Subcellular Location

    Cytoplasm.

  • Target Protein Families

    TRIM/RBCC family

  • Target Synonyms

    E3 ubiquitin ligase ; E3 ubiquitin protein ligase TRIM50; E3 ubiquitin-protein ligase TRIM50; TRI50_HUMAN; TRIM50; TRIM50A ; Tripartite motif containing 50; Tripartite motif containing protein 50; Tripartite motif protein 50; tripartite motif protein 50A ; tripartite motif-containing 50A ; Tripartite motif-containing protein 50

Inquire Recombinant Human E3 ubiquitin-protein ligase TRIM50 (TRIM50) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification